BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Abgenix Incorporated

Abgenix is a biopharmaceutical company focused on the development and commercialization of human therapeutic antibodies. The company’s technology platform, which includes XenoMouse® and XenoMax™ technologies, enables the rapid generation and selection of high affinity, fully human antibody product candidates to a variety of disease targets. Abgenix leverages its leadership position in human antibody technology by building a diversified product portfolio through the development of its own internal proprietary products and through the establishment of licensing arrangements with multiple pharmaceutical, biotechnology and genomics companies. Abgenix’s proprietary products are currently in clinical trials for the treatment of cancer and inflammatory diseases.


Contact Details:
7601 Kaiser Drive
Fremont
CA
94555
United States of America
Tel:510 608 6500
Fax:510 608 6511
Email:busdev@abgenix.com
WWW:

www.abgenix.com/




Loading...

Recent Publications by Abgenix Incorporated:

Elimination mechanisms of therapeutic monoclonal antibodies.
Targeted therapies using monoclonal antibodies have achieved important...
17th March, 2006
Abgenix, Pharmacokinetics & Toxicology, 6701 Kaiser Drive, Fremont, CA Drug Discov Today. 2006 Jan;11(1-2):81-8.
DOI Direct Link
The removal of pyroglutamic acid from monoclonal antibodies without denaturation of the protein chains.
Typically, the removal of pyroglutamate from the protein chains of...
12th October, 2005
Abgenix Corporation, Anal Biochem. 2005 Jul 1;342(1):120-5.
DOI Direct Link
Demonstration of an in vivo generated sub-picomolar affinity fully human monoclonal antibody to interleukin-8.
The high specificity and affinity of monoclonal antibodies make them...
27th September, 2005
Abgenix Biopharma Inc., Burnaby, BC, Canada. Biochem Biophys Res Commun. 2005 Sep 9;334(4):1004-13.
DOI Direct Link
eBLOCKs: enumerating conserved protein blocks to achieve maximal sensitivity and specificity.
Classifying proteins into families and superfamilies allows identification...
16th April, 2005
Abgenix, Inc., 6701 Kaiser Drive, MS 11, Fremont, CA 94555, USA. Nucleic Acids Res. 2005 Jan 1;33(Database issue):D178-82.
DOI Direct Link
Characterizing high-affinity antigen/antibody complexes by kinetic- and equilibrium-based methods.
Two biophysical methods, Biacore and KinExA, were used to kinetically and...
16th December, 2004
Abgenix, Inc., 6701 Kaiser Drive, Fremont, CA 94555, USA. Anal Biochem. 2004 May 1;328(1):35-43.
DOI Direct Link

View more Abgenix Incorporated research publications.

BioNews Results for Abgenix Incorporated:

Takeda San Francisco names new vice president of antibody research
Pharmaceutical Business Review:  Sep 10 2008 10:09AM Matching: abgenix
Takeda San Francisco, Inc. Appoints Gregory Landes, Ph.D. Vice President of Antibody Research
KOTA Territory News:  Sep 8 2008 10:50PM Matching: abgenix
Takeda San Francisco, Inc. Appoints Gregory Landes, Ph.D. Vice President of Antibody Research
KLFY:  Sep 8 2008 5:39PM Matching: abgenix
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
KLFY:  Sep 8 2008 5:37PM Matching: abgenix
Takeda San Francisco, Inc. Appoints Gregory Landes, Ph.D. Vice President of Antibody Research
KSLA:  Sep 8 2008 5:29PM Matching: abgenix
Promote your company here: BioNewsCast - Press Release Distribution

View more Abgenix Incorporated news.

Abgenix Incorporated Patents:

US Patent No.Title
7422742 Methods for using human monoclonal antibodies to interleukin-5
6673986 Generation of xenogeneic antibodies
6657103 Human antibodies derived from immunized xenomice
6458592 Production of antibodies using cre-mediated site-specific recombination
6420140 Production of multimeric protein by cell fusion method

View more Abgenix Incorporated patents.

Abgenix Incorporated (ABGX) Financial information Links from Barchart

ABGX Quote from from Barchart.com
ABGX Chart from from Barchart.com
ABGX Profile from from Barchart.com
ABGX Opinion from from Barchart.com

View more Abgenix Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 825 times since April 2007, the link to the organisation's website has been followed 156 times

Recent Search Terms used to find this page: t | different biacore and KinExA | BioPortfolio Abgenix | t | t | t | greg landes takeda e-mail | abgenix | Abgenix | companies that look for specific recombination | .

Search for more companies in Fremont

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Abgenix Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.